Recent Stock Purchase January 2024

02:35am, Saturday, 03'rd Feb 2024
Recent Stock Purchase January 2024
Interestingly, there are no Big Pharma companies listed in the “Magnificent Seven.” Consequently, perfectly good companies like Pfizer (NYSE: PFE ) are being overlooked, but that's not bad news
Interestingly, there are no Big Pharma companies listed in the “Magnificent Seven.” Consequently, perfectly good companies like Pfizer (NYSE: PFE ) are being overlooked, but that's not bad news

Is the Worst Over for Pfizer?

05:00am, Thursday, 01'st Feb 2024
Pfizer's revenue is on the decline after reaching a record high back in 2022. However, the pharma giant is counting on new product approvals and business deals to spur a new phase of growth.

Pfizer Is Down 54% From Highs, Now Yields 6.1%

03:07pm, Wednesday, 31'st Jan 2024
Pfizer Inc. stock has experienced a significant decline from its all-time high to the lowest price in over 10 years. Despite lower sales from its COVID-19 vaccines, Pfizer's other revenues grew 7% YoY

Listen to Wall Street and Buy These 3 Stocks Now

02:35pm, Wednesday, 31'st Jan 2024
To be blunt, buying a Wall Street recommended stock can be a mixed bag. While we trust experts in say the legal and medical fields, it's a different proposition in the equities space.
Earnings season rolled on with corporate results issued at a fast clip. Overall, results continue to trend in a positive direction.
Pfizer (PFE) reported fourth-quarter earnings on Tuesday morning that beat. Wall Street expectations.
Pfizer Inc. (PFE) Q4 2023 Earnings Call Transcript
Pfizer's (PFE) 4Q adjusted EPS came in at $0.10 versus an estimated -$0.19 and revenue came in at $14.25B versus an estimated $14.36B. Lee Bohl and Sel Hardy discuss the takeaways from Pfizer's earnin
Pfizer reported better-than-expected revenue and adjusted earnings for the fourth quarter. This news spurred a jump for the pharma stock.

Home Prices Decreased in November

12:01pm, Tuesday, 30'th Jan 2024
Pre-market futures are giving back some of the gains we've seen in the past few days of trading — ones which have pumped the Dow and S&P 500 to fresh all-time highs. At this hour, the Dow is -70 poi
While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare
Pfizer (PFE) reports mixed fourth-quarter 2023 results. It re-affirms its 2024 sales and earnings guidance provided in December 2023.
Pfizer Inc (NYSE:PFE)'s shares remained unmoved as its fourth-quarter result beat the Street by showing a surprise profit. For the three months ended December 31, the drugs giant reported earnings pe
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE